CRIPTO3 and systemic lupus erythematosus: Genetic and functional studies implicate under‐functioning CR3 as a risk factor for SLE, suggesting intuitively that augmenting CR3 function may be an effective therapeutic approach 9, 10, 11, 12, 13, 14.